Home
Search results “Prostate cancer metastatic treatment”
Newly Diagnosed Metastatic Prostate Cancer Treatment
 
05:29
Raoul S. Concepcion, MD, FACS, and Daniel George, MD, summarize recent data that suggest the potential for combining newer therapies with androgen deprivation therapy in newly diagnosed metastatic prostate cancer.
Views: 1046 OncLiveTV
Treatment for metastatic prostate cancer in the bones
 
08:42
Prostate cancer often advances to the bones (metastasises to bones). This video (third in a series of five) tells of some special treatments for mets in the bones. Check out the others in our Bones and Advanced Prostate Cancer playlist: https://www.youtube.com/playlist?list=PLvCNVWCC5ca-DcLK6wKQCYrVZ7YZSUk-0 Or check out our full JimJimJimJim YouTube Channel: youtube.com/c/JimJimJimJim Or go straight to one of our advanced prostate cancer playlists: Advanced Prostate Cancer Terms https://www.youtube.com/playlist?list=PLvCNVWCC5ca_nS1GqWJg-v7fiMzbxT6Jd Advanced Prostate Cancer Stories https://www.youtube.com/playlist?list=PLvCNVWCC5ca9lyb0I9G3ktq7cDsZf_WSy Latest Developments in Advanced Prostate Cancer https://www.youtube.com/playlist?list=PLvCNVWCC5ca_spTBbXTsUsVuCBxbRd6bx Prostate Cancer Patient Conferences https://www.youtube.com/playlist?list=PLvCNVWCC5ca8q7Ft0u5sY3y45finVI-kO Australia (only) Advanced Prostate Cancer Issues https://www.youtube.com/playlist?list=PLvCNVWCC5ca_svbXebULuZM7HK-oLwJZ7 Our forums: JimJimJimJim.com, Click on the blue ribbon. Australian men can join the Australian Advanced Prostate Cancer Support Group there. The Australian Advanced Prostate Cancer Support Group is affiliated with the Prostate Cancer Foundation of Australia (PCFA). Credits freepik.com/free-vector/human-skeleton-template_838491.htm Brian Ward: Australian bird calls "Carefree" Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 English Closed Captions (Cc): Len Weis Production Assistance: John Dowling Production Funding: Prostate Cancer Foundation of Australia (PCFA) Education Grant
Views: 4549 JimJimJimJim
New treatment options in metastatic prostate cancer
 
11:07
Dr Shore (Carolina Urologic Research Center, Myrtle Beach, USA) and Dr Merseburger (University Hospital Schleswig-Holstein, Lübeck, Germany) discuss new treatment options for metastatic prostate cancer for ecancertv at ASCO GU 2016. They discuss an open-label phase II study which evaluated the efficacy of concurrent administration of radium Ra 223 dichloride (Ra-223) and abiraterone acetate (AA) in men with castration-resistant prostate cancer (CRPC) with symptomatic bone metastases. They also consider a new option arising for those CRPC patients who have become resistant to abiraterone and enzalutamide - the dual CYP17-Lyase (L) inhibitor / androgen receptor (AR) antagonist VT-464. This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).
Views: 9384 ecancer
Advanced Prostate Cancer: Living Longer, Living Better
 
07:57
Treatment options for advanced prostate cancer.
Views: 1041 ChesapeakeUrology
Prostate Cancer Treatment (03): Patterns of Spread
 
02:49
Alta Bates Summit Medical Center, Oakland and Berkeley, CA Prostate Cancer Treatment Options (03): Patterns of Spread Video for Men Recently Diagnosed with Prostate Cancer: The purpose of this video is to guide you through the stages of the disease, describe factors that affect prognosis, and discuss various treatments that may be appropriate for you. We don't endorse or recommend one course of treatment over another, but rather provide this information to help you understand your options before you consult with your doctors about your treatment plan. Please note that viewing this video online works best over a high speed Internet connection. If you'd prefer to receive a DVD copy, please call our office at (510) 869-8833.
Treatment for advanced (metastatic) prostate cancer
 
03:09
In this cancer information video, Urologist Shiv Bhanot explains the treatment options for advanced (metastatic) prostate cancer. He talks about hormonal treatment, anti-androgen withdrawal therapy and chemotherapy. It also features Patrick, who talks about coping through treatment for prostate cancer. Subscribe: http://bit.ly/UsAbto Twitter: https://twitter.com/macmillancancer Facebook: https://www.facebook.com/macmillancancer
Treatment of Bone Metastases in Prostate Cancer
 
06:37
Raoul S. Concepcion, MD, and Michael S. Cookson, MD, MMHC, discuss how to treat castration-resistant prostate cancer in a patient with bone-only metastases.
Views: 2390 OncLiveTV
ASCO 2018: Novel treatment strategies in prostate cancer therapeutics
 
14:58
Dr Neal Shore speaks to Prof Karim Fizazi about the changing landscape of treatments for prostate cancer, discussing immunotherapies, PARP inhibitors and PSMA testing as future targets and treatments. Dr Fizazi highlights that anti-PD1 treatment (pembrolizumab) may provide benefit for metastatic castration resistant patients following antiandrogen treatment (5 of the 28 patients in the trial had a PSA decline of 50%). Trials building on immune checkpoint therapies with novel combinations to improve response rates have shown promise. Among these, the combination of pembrolizumab and enzalutamide is being explored as a doublet or a triplet with the addition of ADXS-PSA in KEYNOTE-046. Dr Shore raises PARP inhibitors as an avenue of research, with the recent TOPARP trial confirming the activity of olaparib, and Prof Fizazi considers how different genetic abnormalities will inform selection in upcoming trials and eventual care. PSMA testing, already providing new insights when used in combination with PET imaging, may also offer new inroads in developing treatments, and Prof Fizazi summarises current clinical interest in targeted or radiologic medicine.
Views: 442 ecancer
PSA Elevation After Treatment For Prostate Cancer
 
11:34
Men treated for prostate cancer with radiation or surgery need to have a regular PSA examination. If the PSA rises after treatment, it may indicate recurrence of the cancer. This video describes the evaluation for men who have an elevated PSA after treatment and what are the next options if there is a recurrence of prostate cancer.
Views: 9157 Neil Baum
Treatment to stop prostate cancer cells growing in the bone
 
04:01
Prostate Cancer Metastasis (ProMis): New Opportunities for Therapeutic Development by Professor Peter Croucher, Garvin Institute of Medical Research
Gleason Score & Prostate Cancer Treatments | Memorial Sloan Kettering
 
09:28
Learn about MSK: https://www.mskcc.org CONNECT WITH MSK Facebook: http://facebook.com/sloankettering Twitter: http://twitter.com/sloan_kettering Instagram: http://instagram.com/sloankettering Request an appointment at MSK by calling 800-525-2225 or online at: https://www.mskcc.org/appointments/request-appointment Prostate cancer patients are considered high- or low-risk in part based on their Gleason score. Doctors use this tool to determine whether a patient's first treatment should be surgery or radiation, specialists at Memorial Sloan Kettering Cancer Center say. {partial transcript} Let’s say we’ve got an elevated PSA – went for a biopsy and now have been diagnosed with prostate cancer. What I think most men and most people in the audience are interested in hearing is what to do next: Do I do surgery or do I choose radiation? Where do I go from here? Let’s talk about some of the pros and cons of surgery. It used to be recommended that surgery was more for younger men and disease confined to the prostate? We certainly reserve surgery for men that have a ten-year life expectancy at least. Men with less than a ten-year life expectancy can be probably treated in other ways that are much less difficult to go through. In the end, surgery is an assault; it basically is an operation that one has to go through. There is a hospital stay. There are catheters. Simply put, there is a lot a person has to go through with an operation, that if a man does not have a reasonable life expectancy, it is probably not worth going through. That’s not always true for individual patients, but most men who have less than a ten-year life expectancy will be treated with some other modality. A ten-year life expectancy of someone is now age 75, so it’s not as though there should be an age cut off, per se…
Metastatic Prostate Cancer Treatment Options
 
02:14
Mayo Clinic Dr. Igor Frank discusses treatment options for patients with metastatic prostate cancer, and recommendations for follow up doctor visits and on-going PSA monitoring.
Views: 5352 Mayo Clinic
New prostate cancer treatment- Natural Prostate  Treatment - Natural - Effective- no side effect
 
08:50
For prostate cancer, our treatment consists of several steps. First, we determine the location and size of the prostate cancer lesions by Digital Rectal Examination (DRE), Trans Rectal UltraSound (TRUS), and pelvic Nuclear Magnetic Resonance Imaging (MRI) examination. And then we targeted inject a set of anti-cancer herbal extracts without any side effects into the prostate cancer lesion area in high concentrations by using 3D targeted injection technology, thus directly inhibiting and killing cancer cells, making the prostate cancerous tissue atrophy and necrotize. At the same time, we targeted inject unblocking herbal extracts without any side effects to resolve the pathogenic tissue and prostatic endotoxin, and discharge toxic substances. In addition, we use some other herbal extracts without any side effects to improve and restore prostate immunity and the blood circulation to prevent the recurrence of prostate cancer. Through 3D Prostate Targeted Treatment, the volume of the prostate cancer lesions will shrink or disappear, and the patient’s symptoms should be improved or disappear. At the first and second clinical stages (I-II stages), prostate cancer lesion is only confined to the prostate capsule. At this time, we inject a set of anti-cancer herbal extracts and unblocking herbal extracts within the prostate cancer lesion for treatment. At the third clinical stage (III stage), prostate cancer lesion goes beyond the prostate capsule and invades neighboring tissues and organs like seminal vesicle, bladder neck etc. We targeted inject treatment medicines within the prostate capsule to treat the primary lesion, and we also apply 3D targeted injection technology to put a set of anti-cancer treatment medications into adjacent seminal vesicle, the bladder neck and other neighboring tissues and organs for treatment. At the fourth clinical stage (IV stage), prostate cancer lesion spreads beyond the prostate by transferring lesions to distant bones, or even lungs, liver and adrenal gland. We targeted inject treatment medicines within the prostate capsule to treat the primary lesion; at the same time, we couple with systemic treatment and local targeted injection treatment of distant metastasis lesions. The treatment medications include anti-cancer herbal extracts, unblocking herbal extracts, and improving immunity herbal extracts. Our clinical use of medicines have no side effects. Because prostate cancer normally happens in older people, the cancer nodules will press on the prostate tubes, ejaculatory ducts and posterior urethra, prostate cancer patients usually may also have prostatitis and genitourinary tract infection, 3D Prostate Targeted Treatment can treat these diseases at the same time. 3D Prostate Targeted Treatment is very suitable for prostate cancer patients who also have prostatitis and benign prostatic hyperplasia. 3D Prostate Targeted Treatment is an non-surgical method that causes no harm, no side-effects with no ongoing consequences of the original disease, to completely treat prostate cancer. 3D Prostate Targeted Treatment is not a long-term medicinal treatment and so it is the best treatment for prostate cancer as it causes no side-effects. At present, 3D Prostate Targeted Treatment is not suitable for distant metastases of prostate cancer, including bone metastases, lung metastases, liver metastases and adrenal glands metastases. Mr. John Kennedy Medical report link: https://www.prostatecancer.vip/cancer.html Mr. Barry Saunders Medical report link: https://www.prostatecancer.vip/cancer.html 3D prostatitis and Prostate Clinic Miss Alisa Wang English Assistant to Dr. Song Tel:86-186-7321-6429 WhatsApp:+ 86 -186-73216429 Email: prostatecure3d@gmail.com Website: https://www.prostatecancer.vip/cancer.html The Xiangtan 3D Urology and Prostate Clinics Address - Jin Xiangtan Square Office Building, Suite 801, Shao Shan Middle Rd., Xiangtan, Hunan, China.
Views: 340806 Alisa Wang
Prostate Cancer Treatment Decisions
 
13:00
For men with prostate cancer, how to decide between active surveillance or watchful waiting versus active therapy like radiation or surgery
Views: 516 Robert Miller
Treating Advanced Prostate Cancer with Diet: Part 2
 
05:50
What happens when metastatic prostate cancer patients were taught to increase intake of whole grains, vegetables, fruit, and beans and to decrease meat, dairy, and junk? Subscribe to Dr. Greger’s free nutrition newsletter at https://www.nutritionfacts.org/subscribe and get a free recipe from his new HOW NOT TO DIE COOKBOOK. (All proceeds Dr. Greger receives from his books, DVDs, and speaking directly support NutritionFacts.org). Support NutritionFacts.org with a donation at http://www.NutritionFacts.org/donate. Healthy diets only work if you eat them, though. Check out the earlier study in my last video, Treating Advanced Prostate Cancer with Diet: Part 1 (https://nutritionfacts.org/video/treating-advanced-prostate-cancer-with-diet-part-1). Why is it so hard to get men to change their diet even in the face of cancer? Watch my video Changing a Man’s Diet After a Prostate Cancer Diagnosis (https://nutritionfacts.org/video/changing-mans-diet-prostate-cancer-diagnosis/). Have a question about this video? Leave it in the comment section at http://nutritionfacts.org/video/treating-advanced-prostate-cancer-with-diet-part-2 and someone on the NutritionFacts.org team will try to answer it. Want to get a list of links to all the scientific sources used in this video? Click on Sources Cited at http://nutritionfacts.org/video/treating-advanced-prostate-cancer-with-diet-part-2. You’ll also find a transcript and acknowledgements for the video, my blog and speaking tour schedule, and an easy way to search (by translated language even) through our videos spanning more than 2,000 health topics. If you’d rather watch these videos on YouTube, subscribe to my YouTube Channel here: https://www.youtube.com/subscription_center?add_user=nutritionfactsorg Thanks for watching. I hope you’ll join in the evidence-based nutrition revolution! -Michael Greger, MD FACLM http://www.NutritionFacts.org • Subscribe: http://www.NutritionFacts.org/subscribe • Donate: http://www.NutritionFacts.org/donate • HOW NOT TO DIE: http://nutritionfacts.org/book • Facebook: http://www.facebook.com/NutritionFacts.org • Twitter: http://www.twitter.com/nutrition_facts • Instagram: http://instagram.com/nutrition_facts_org/ • Google+: https://plus.google.com/+NutritionfactsOrgMD • Podcast : http://nutritionfacts.org/audio/
Views: 54976 NutritionFacts.org
Can Advanced Prostate Cancer Be Cured?
 
02:47
When the disease spreads beyond the prostate, it becomes more difficult to manage. A small percentage of men are able to be cured if their cancer has only spread to the lymph nodes. If prostate cancer has spread beyond the lymph nodes and to, for example, the bones, the treatment changes from curative to trying to find treatments that allow a man to live as long as possible. VIEW ON THE WEBSITE: http://www.prostatecancerlive.com/advanced-prostate-cancer-cure/ LAST WEEK'S VIDEO - Ejaculation after Prostate Surgery http://www.youtube.com/watch?v=oahZ8safFDI SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING PROSTATE CANCER NEWS http://youtube.com/subscription_center?add_user=prostatecancerlive. VISIT PROSTATECANCERLIVE.com FOR TONS OF INFORMATIVE VIDEOS http://www.prostatecancerlive.com/# SUGGEST THE NEXT TOPIC FOR OUR PROSTATE CANCER EXPERTS! http://www.prostatecancerlive.com/ CONNECT WITH US! Google+: http://bit.ly/17F4WQr Facebook: https://www.facebook.com/pages/Prosta... Twitter: https://twitter.com/ProstateLive
Views: 9394 Prostate Cancer Live
Advanced Prostate Cancer
 
01:13:14
(Visit: http://www.uctv.tv) Prostate cancer kills approximately 30,000 men in the US every year. For many, the disease is highly treatable and can be controlled with medical therapy for many years. An understanding of the factors that drive prostate cancer to become potentially lethal has led to a variety of new treatments that go far beyond standard chemotherapy approaches to cancer. Patients with advanced prostate cancer are currently treated with combinations and sequences of immunotherapies, hormonal approaches and chemotherapy. UCSF oncologist Dr. Charles J. Ryan covers the clinical and biological factors that drive treatment choice and sequence by physicians, and highlights how prostate cancer therapies are emblematic of the progress that is being made against cancer in general. Further, he addresses the challenges faced by patients and doctors and the research being done to address them. Recorded on 06/17/2014. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [9/2014] [Health and Medicine] [Show ID: 28498]
How is stage 4 prostate cancer treated? - Dr. Anil Kamath
 
02:08
For more, download the app - http://drcl.in/videoapp Now stage 4 or meta static prostate cancer few patients are detect at this stage. The main treatment for this is hormone therapy. Now the development of prostate cancer is mainly related to the male hormone. The development of prostate cancer is mainly related to the male hormone for androgen. These hormones are produced by the testis in male. Now depriving the prostate of this hormone automatically leads to sinking of the prostate and control of the tumour. One of the effective ways of treating metastatic prostate cancer is by depriving these hormone by removal of both testis. It is removed not because of the disease but it is a source of hormone androgen for development and spread of cancer. Now those patients who are not agree to remove testis for them there is other option like injection. But one thing injection is stopped the androgen start produced again then there are tablets which block androgen production. Besides this there are new treatment option like biological therapy which are coming up in recent research work. So these are various ways to treat prostate cancer. For Appointments, https://doctorscircle.in/bangalore/doctor/surgical.../dr-anil-kamath For more, download the app - http://drcl.in/videoapp
Metastatic Prostate Cancer: Causes, Symptoms and Treatment | Usapang Pangkalusugan
 
18:59
Resident Urologist Dr. Joseph Lee enumerates the symptoms, complications, treatment and other important details everybody should know about Metastatic Prostate Cancer. Click this video for more. For more videos: http://www.untvweb.com/video/ For News Update, visit: http://www.untvweb.com/news/ Check out our official social media accounts: http://www.facebook.com/UNTVNewsRescue http://www.twitter.com/untvnewsrescue https://www.youtube.com/UNTVNewsandRescue Instagram account - @UNTVLife Feel free to share but do not re-upload. #GoodMorningKuya
Hormone Therapy in Prostate Cancer
 
05:12
Medical oncologist Michael Morris talks about the benefits and risks of hormone therapy for men with metastatic prostate cancer.
Prostate Cancer and Bone Metastasis
 
07:45
The most common place for prostate cancer to spread is to the bone. The spread of the prostate cancer to the bones (bone metastases) can cause severe pain and fracture, and hormonal therapy for prostate cancer can cause bone loss, fracture, and joint pain.
Immunotherapy: The Future of Prostate Cancer is Here, with Charles Drake
 
48:16
On September 30, 2014, Charles G. Drake, M.D., Ph.D., an associate professor of oncology at Johns Hopkins University, discussed current immunotherapy treatment options for patients with prostate cancer, and how close we are to making these treatments available to more patients. This 45-minute online webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series, was generously supported by Dendreon. These webinars are offered free to the public and feature informative updates from leaders in cancer immunotherapy, followed by a moderated Q&A. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.
Treatment Options for Metastatic Prostate Cancer
 
03:32
Daniel J. George, MD, discusses treatment options for a patient with prostate cancer who has developed bone metastases. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 51 Targeted Oncology
Targeting TRAF6 for the Treatment of Prostate Cancer Metastases.
 
01:25
Prostate cancer is the most common type of cancer in men and is the fifth leading cause of cancer death worldwide. The majority of deaths from prostate cancer following conventional therapies are a result of metastases. TRAF6, a key component of NFkB pathway, is implicated in tumour growth, metastasis and T-cell exhaustion in prostate cancer. The aims of Miss Carrasco-Gonzalez’s PhD is to test the effects of pharmacological inhibition and genetic manipulation of TRAF6 – alone or in combination with conventional anti-cancer therapies- on tumour growth, metastasis and anti-tumour immunity in humanized and syngeneic mouse models of prostate cancer, and determine the mechanism by which TRAF6 influences prostate cancer tumorigenesis and metastasis. If successful, the findings of this research will have translational potential in identifying TRAF6 inhibitors - alone or in combination therapy - for the treatment of metastatic prostate cancer. This addresses a huge unmet clinical need, as metastasis and acquired resistance to conventional chemotherapeutic agents are major clinical problems.
Views: 252 Aymen Idris
Stage 4 Prostate Cancer with Bone metastasis healed Dr. Farrah Bunch
 
02:52
Even Doctors get stage 4 cancer. Hear Dr. Prodencio's inspiring journey back from the edge. To know more about natural medicine, immunotherapy, and Dr. Farrah, Visit us at: http://drfarrahcancercenter.com/ https://www.facebook.com/DrFarrahBunch/
Radium-223 and Metastatic Prostate Cancer
 
02:14
In a study involving men with castration-resistant prostate cancer and bone metastases, the alpha emitter radium-223 significantly prolonged survival, as compared with placebo, and was associated with fewer adverse events. See the NEJM article: http://www.nejm.org/doi/full/10.1056/NEJMoa1213755
Views: 10279 NEJMvideo
Treating Prostate Cancer with Chemotherapy
 
02:47
Dr. Geo Espinosa, ND, LAc, IFMCP, CNS, clinical assistant professor of integrative and functional urology at New York University and author of Thrive—Don’t Survive: Dr. Geo’s Guide to Living Your Best Life Before & After Prostate Cancer, discusses treating prostate cancer with chemotherapy. Chemotherapy is not the most common treatment for prostate cancer, though it is used more often in advanced cases. As most cases of this cancer are low or intermediate grade, other treatments are more effective than chemo, even in cases where the cancer has metastasized beyond the prostate. Doctors and patients should work together to create a treatment regimen that is appropriate for the patient. Don’t be afraid to ask questions about the treatments your doctor proposes.
Views: 133 Bottom Line Inc
Conclusion: Final Thoughts on Treating Metastatic Prostate Cancer
 
09:22
In the final clip of the discussion, panelists discusses the treatment of men with metastatic castration-resistant prostate cancer, as treatments continues to evolve and gain approval. To view the rest of the discussion, visit http://www.onclive.com/peer-exchange/crpc-cases
Views: 1081 OncLiveTV
Advances in prevention and treatment of bone metastases in prostate cancer
 
04:49
Winston Tan, MD of Mayo Clinic, Jacksonville, FL discusses a treatment of bone metastases in prostate cancer. Dr Tan mentions that addition of bisphosphonates does not increase the overall survival of patients suffering from various cancer types, including breast cancer, prostate cancer, and renal cancer. Cabozantinib, approved for metastatic renal cancer makes the bone metastases disappear, however, it has not been shown to increase survival in patients with a metastatic prostate cancer in a phase III randomised clinical trial. A combination of two or three drugs may be required to achieve better results in patients. The next step would be to look at markers, a combination of targets and drugs which can work together to help improve survival and prevent the consequences of bone metastases. Dr Tan highlights the importance of supportive care for cancer patients, who can benefit from an access to physical therapists, psychologists, and nutritionists. This could mean less bone pain and decreased use of pain medication, which may cause dizziness, constipation, or reduced mobility. Ongoing studies in the metastatic prostate cancer compare the micro-environmental factors, before and after the treatment to better understand which genetic and metabolic factors affect the bone metastases. Dr Tan says that prostate cancer patients with bone pain should be offered Radium 223, which improves survival and long-term can improve the symptomatology, and bisphosphonates, or denosumab, which is known to prevent skeletal-related events. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Ocular Oncology (ISOO) 2016 Annual Meeting on Supportive Care in Cancer held in Adelaide, Australia.
Views: 370 VJOncology
Options for Metastatic Castrate-Resistant Prostate Cancer
 
05:44
‘When prostate cancer progresses despite low levels of testosterone, it is called castrate- resistant prostate cancer. Today, thanks to clinical research, there are options for patients whose prostate cancer has advanced while on hormonal therapy. Ongoing clinical trial research offers more than additional treatment options; it offers hope to both patients living with advanced/metastatic disease and the physicians who are treating them. “The availability of all these different options that we now can offer patients with castrate resistant prostate cancer has more than doubled the amount of time men live with the disease, has significantly improved their quality of life, and has allowed them to take advantage of life at home rather than in the hospice suffering from prostate cancer. “ ~ Dr Fred Saad, MD, FRCSC Researcher and Head of Urologic Oncology University of Montreal Hospital Centre (CHUM) “I’m living proof that research and excellence in cancer treatment matters. And, my goal for my kids and your kids is that they won’t ever have to deal with this in their lifetime.” ~Don Konantz, Advanced Prostate Cancer Survivor
Views: 234 editextreme
Advice for Patients with Prostate Cancer
 
03:52
Just been diagnosed with Prostate Cancer? Get sound advice from Edward Weber, M.D. At pctrf.org, you can find help. Prostate Cancer takes years to develop to where it can be diagnosed. Rising PSA, Biopsy or DRE? You didn't just get prostate cancer, you have just been diagnosed with cancer. Take your time, to learn the options. Schedule appointments with specialist. Sessions with Urological Surgeons, Radiation Therapists and Medical Oncologists can help you sort through the Treatment Options. Do you choose Active Surveillance, Surgery, External Beam Radiation, Seed or Brachytherapy, Proton Therapy, Cryotherapy, Cyberknife, or some other treatment? The Prostate Cancer Treatment Research Foundation can help you with this process. On our website, we provide a simple way for you to view the results of different prostate cancer treatments across thousands of patients for as long as fifteen years. Visit our website at https://.prostatecancerfree.org Video Development - Dean Dubinsky Video Transcript: Prostate Cancer Free Foundation. Increasing Knowledge - Building Hope. Edward Weber, M.D. Medical Oncologist, Prostate Cancer Results Study Group. You’ve been diagnosed with prostate cancer. If your diagnosis came as a result of a schedule of appropriate PSA testing, it’s very likely the disease has been found early. This comes as a surprise to most men and they are quite anxious at this point. Being told you have prostate cancer is a frighting message carrying a heavy baggage The normal urge is to plunge into a “crash course” to learn how to manage this unwelcome intrusion into your life, a crash course that you are unlikely to know how to handle objectively. So … what to do?  Stop, take a deep breath, step back a bit, and think carefully. It is extremely unusual that there is any need to rush to a decision. Most cancers have been sitting quietly in your prostate and growing for 10 to 15 years, with the most aggressive ones developing over 10 or so years. So … you haven’t just “gotten” prostate cancer. You just have been “diagnosed” with a cancer that you have been living with for a long time. Likely your diagnosis has been made by a biopsy performed by a urologist, an expert in the surgical management of prostate cancer. It’s extremely important for you to know that any cancer, low grade, intermediate, or high grade can be successfully treated with surgery, augmented if need be by radiation, external beam radiation therapy, permanent radioactive seed placement, for example brachytherapy, combined if indicated by external radiation, and proton therapy. In some cases cryotherapy or short course of focused radiation with Cyberknife technology is chosen.  Active surveillance is a very important option for management of low-risk cancer. It warrants serious consideration and discussion. Take your time and learn about the treatment options available to you. You may want to consider several of these. In most situations, all of these are reasonable options. But for some men their individual  situations makes a particular option the better choice. Nor do all options suit every man’s emotional reaction to the diagnosis or his preferences.  So what should you do? You do not need to become an instant expert. Instead, you need to have consultations with possibly several specialists who can describe their treatments and help you decide which treatment fits you best. In the process you may well have consultations with a urological surgeon and possibly several radiation therapists each skilled in a special type of radiation therapy. If your disease is more complex, you may want an option from medical oncologist, which is what I am. It’s important to be informed, but you don't need to do this alone. That’s what the specialists are there for. This is the time for deliberation, since once treated you cannot reverse the course. After stopping, and thinking, and gaining expert guidance, then take action. Most not all of the mental fuzz of anxiety and consternation will subside. But when you have made a considered decision you will feel very comfortable.  Then you can devote your energy to the goal of successful treatment and recovery. The outcome of therapy for this disease is generally excellent, very likely much better than you might have thought. With careful deliberation on your part and treatment by experts, your will be able to make this usual good outcome your outcome. Prostate Cancer Free Foundation. https://prostatecancerfree.org
What is Life Expectancy for Stage 4 Prostate Cancer?
 
03:44
A Stage 4 prostate cancer diagnosis is reserved for those whose cancer has progressed outside the prostate to other organs. Usually the cancer is no longer responding to hormonal therapy at this point. There are a variety of medications available for patients with this diagnosis to help extend their length and quality of life. Dr. Howard Tay discusses these medications and life expectancy with Stage 4 prostate cancer in this video. VIEW THE ARTICLE: Life Expectancy with Stage 4 Prostate Cancer - http://www.prostatecancerlive.com/?p=13652 SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING PROSTATE CANCER NEWS http://youtube.com/subscription_cente... VISIT PROSTATECANCERLIVE.com FOR TONS OF INFORMATIVE VIDEOS http://www.prostatecancerlive.com/# SUGGEST THE NEXT TOPIC FOR OUR PROSTATE CANCER EXPERTS! http://www.prostatecancerlive.com/# CONNECT WITH US! Google+: http://bit.ly/17F4WQr Facebook: https://www.facebook.com/pages/ProstateCancerLive Twitter: https://twitter.com/ProstateLive
Views: 48173 Prostate Cancer Live
David's story - 7 years with metastatic prostate cancer
 
11:38
More than seven and a half years ago David was diagnosed with metastatic prostate cancer. David tells the story of his journey over those years.
Views: 19286 JimJimJimJim
What are the Treatment Options for Stage 4 Prostate Cancer?
 
06:49
A person is diagnosed with Stage 4 prostate cancer when the cancer is in other organs. Often, it is found in a patient's bones, but can be found all over. There are different treatments available for patients today. Which treatment options are the best depend on several factors. Dr. Howard Tay is an experienced Urologist. Here he discusses the treatment options for Stage 4 prostate cancer. Every cancer is different and needs a personalized treatment path. Dr. Tay describes what those paths might look like in the video below. VIEW THE ARTICLE: Treatment Options for Stage 4 Prostate Cancer - http://www.prostatecancerlive.com/?p=13623 SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING PROSTATE CANCER NEWS http://youtube.com/subscription_cente... VISIT PROSTATECANCERLIVE.com FOR TONS OF INFORMATIVE VIDEOS http://www.prostatecancerlive.com/# SUGGEST THE NEXT TOPIC FOR OUR PROSTATE CANCER EXPERTS! http://www.prostatecancerlive.com/# CONNECT WITH US! Google+: http://bit.ly/17F4WQr Facebook: https://www.facebook.com/pages/ProstateCancerLive Twitter: https://twitter.com/ProstateLive
Views: 11035 Prostate Cancer Live
Updates in metastatic prostate cancer
 
15:46
Professor Heather Payne, Dr Neal Shore, Dr Eleni Efstathiou and Professor Nicolas Mottet discuss the management of patients with metastatic hormone sensitive prostate cancer (mHSPC) and the anticipated impact the data presented at the 2018 ASCO Genitourinary Cancers Symposium will have on the management of this patient group. They discuss how data presented over the last few years has changed the approach to management of patients with mHSPC. The conversation also focuses on how to best stratify patients and whether volume of disease impacts treatment decisions. The panel discuss the disease features and patient charactistics that influence choice of therapy for patients with hormones sensitive disease and the importance of a shared discussion between patients and clinicians when making these treatment decisions. This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).
Views: 439 ecancer
Say No   to Hormone  Therapy for Prostate Cancer
 
23:26
Say No to Hormone Therapy for prostate cancer Androgen deprivation therapy (ADT), is an antihormone therapy whose main use is in treating prostate cancer. There is mounting evidence that androgen deprivation therapy (ADT) for prostate cancer carries significant health risks .ADT accelerates aging. A man decides to check his prostate specific antigen (PSA). He faces two hazards: 1. False diagnosis- While elevated PSA indicates that he got prostatitis, according to medicine he got cancer. 2. He is treated with androgen deprivation therapy(ADT) which is toxic. Medicine does not fully understand cancer progression. Prostate cancer starts as a chronic inflammation (prostatitis) in which cancer emerges. I shall start with a description of uterine cancer and compare is with prostate cancer progression. Actually all cancers progress in the same way. Chronic virus infection is responded by a dysplastic field in which tumor emerges. Dysplastic fields have the same topology determined by distinct gene sets called Dysplasia gene sets Prostate glands secrete prostate-specific antigen (PSA), a glycoprotein enzyme secreted by the epithelial cells of the prostate gland. PSA is produced for the ejaculate, where it liquefies semen Androgen deprivation therapy (ADT), also called androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones, with drugs or surgery, to prevent the prostate cancer cells from grow
Views: 4533 Gershom Zajicek M.D,
Surgery vs radiotherapy: what is the most effective treatment for prostate cancer?
 
04:29
Prasanna Sooriakumaran (PS) discusses the merits of surgery versus radiotherapy for treating prostate cancer in his BMJ study, which concluded that for most men with non-metastatic prostate cancer, surgery leads to better survival than does radiotherapy. Download the full study here: https://www.santishealth.org/wp-content/themes/santis/resources/papers/01-prasanna-sooriakumaran-paper-surgery-versus-radiotherapy.pdf
Views: 545 Santis
Prostate cancer laser treatment 'truly transformative' - BBC News
 
02:24
Surgeons have described a new treatment for early stage prostate cancer as "truly transformative". The approach, tested across Europe, uses lasers and a drug made from deep sea bacteria to eliminate tumours, but without causing severe side effects. Trials on 413 men - published in The Lancet Oncology - showed nearly half of them had no remaining trace of cancer. Lifelong impotence and incontinence are often the price of treating prostate cancer with surgery or radiotherapy. Please subscribe HERE http://bit.ly/1rbfUog World In Pictures https://www.youtube.com/playlist?list=PLS3XGZxi7cBX37n4R0UGJN-TLiQOm7ZTP Big Hitters https://www.youtube.com/playlist?list=PLS3XGZxi7cBUME-LUrFkDwFmiEc3jwMXP Just Good News https://www.youtube.com/playlist?list=PLS3XGZxi7cBUsYo_P26cjihXLN-k3w246
Views: 21511 BBC News
Dr. Patel on Early Treatment With Docetaxel for Metastatic Prostate Cancer
 
02:09
Jyoti D. Patel, MD, ASCO expert, associate professor, Northwestern University Feinberg School of Medicine, discusses the early treatment of patients with metastatic prostate cancer. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 293 Targeted Oncology
Identifying Bone Progression in Metastatic Prostate Cancer and Treatment Options
 
12:33
Panelists Raoul S. Concepcion, MD; Alicia K. Morgans, MD, MPH; Daniel R. Saltzstein, MD; and Jorge A. Garcia, MD, describe how to identify bone progression in metastatic prostate cancer and the treatment options available.
Views: 1311 OncLiveTV
Prostate Cancer Stage Predicts Spread of Disease
 
04:19
prostate cancer,cancer,breast cancer,prostate cancer medscape,prostate cancer treatments compared,prostate cancer treatments options,prostrate cancer treatment,prostate cancer treatment options
Views: 3244 MedicineForEveryone
Case Study: Treating Asymptomatic Metastatic Castration-Resistant Prostate Cancer
 
08:14
In the fourth installment of this case-based discussion, Raoul S. Concepcion, MD, notes that the patient has progressed to asymptomatic metastatic castration-resistant prostate cancer. Given these new criteria, the panelists discuss their next treatment choice for this patient. To view more from this discussion, visit http://www.onclive.com/peer-exchange/crpc-cases
Views: 818 OncLiveTV
Evolution of Treatment for Metastatic Castration-Resistant Prostate Cancer
 
06:16
The panelists discuss the evolution of treatment for patients with mCRPC, from the introduction of docetaxel to the advent of newer agents including cabazitaxel. For more from this discussion, visit http://www.onclive.com/peer-exchange/treating-mcrpc
Views: 475 OncLiveTV
How to Recognize Prostate Cancer Symptoms|metastatic prostate cancer treatment
 
05:32
How to Recognize Prostate Cancer Symptoms|metastatic prostate cancer treatment Prostate cancer is the most common cancer among men and the second leading cause of cancer-related death in men in the United States.[1] The average age at the time of diagnosis is about 66 years old, with about six cases in 10 diagnosed in men aged 65 or older and very few diagnosed before age 40.[2] Prostate cancer can have no symptoms at all and there is no definitive screening protocol for cancer, due to false positives and false negatives among current screening tests. When detected, 90% of cancers are found locally within the prostate and have not spread to other parts of the body, which means that nearly 100% of men at this stage are disease-free after five years.[3] If you are worried about prostate cancer, learn to recognize the symptoms and increase your awareness around testing and the stages of prostate cancer so that you get treatment as quickly as possible. 1 Visit your doctor. It is advised to seek medical advice if you have any of the symptoms of prostate cancer. There are many other possible diagnoses, such as prostatitis, urinary tract infection, and benign prostatic hyperplasia, that can mimic cancer but it is best to rule out prostate cancer as soon as possible. Your doctor will take a detailed history and physical examination to order the appropriate workup, and will ask about your symptoms, family history, diet, sexual history, and the use of any substances such as drugs or tobacco. 2 Know how your doctor will diagnose prostate cancer. While you can tell your doctor about your symptoms, a clear diagnosis can only be done with specific medical tests. If cancer is probable or needs to be investigated, your doctor can perform a variety of screening exams or tests:[22] Digital rectal examination (DRE). Your doctor will feel for your prostate with a gloved and lubricated index finger through your rectum. The doctor will then palpate the part of your rectum facing your belly button; the prostate lies above/in front. The doctor is feeling for any irregular shapes (lumps and bumps), contour (smooth or not smooth), size and tenderness. Abnormal findings include firm, bumpy, nonsmooth, and enlarged prostate. Normal DRE does not rule out prostate cancer unfortunately. Prostate specific antigen (PSA) blood test. Your doctor will insert a needle in your arm and collect blood and send it out for detection of PSA. This is a specific protein found in your prostate. Most doctors conclude a level of 4ng/ml or lower is considered normal. Men with a PSA level between four and 10 have about a one in four chance of having prostate cancer. If the PSA is more than 10, the chance of having prostate cancer is over 50% (10). PSA levels cause false positive or false negative results. Elevated levels may not indicate prostate cancer or issues — it serves as a guide. Normal levels do not indicate you don't have cancer. Ejaculation (recent sexual activity), prostate infection, digital rectal examination and bike riding (this puts pressure on the prostate) can cause elevations of PSA. Those without prostate symptoms and elevated PSA may require repeat testing after two days. Repeat elevated PSA levels may warrant a DRE and/or biopsy of the prostate (needle inserted to take a piece of the prostate tissue for analysis) if symptoms are present. Cancer can occur even with normal results from the PSA test. TransRectal Ultrasound (TRUS). A small lubricated probe will be inserted into the rectum and emit sound waves that can produce a picture on the screen. What the doctor is looking for is enlarged size, abnormal shape and contour. This method cannot always tell the difference between normal and prostate cancer. Biopsy. This involves using a TRUS to guide a needle into the prostate gland and take a sample of the tissue for analysis. Your doctor will sample more than one area of the prostate for analysis. This is a definitive test for both BPH and prostate cancer. Your doctor may elect to undergo this if there is high level of suspicion but previous studies have come back negative/normal. A pathologist will use a Gleason grading system to analyze the tissue biopsy of the prostate SUBSCRIBE TO MORE VIDEOS
Views: 82 health gym
Immunotherapy and the Abscopal Effect in Treating Metastatic Prostate Cancer
 
06:14
Panelists Raoul S. Concepcion, MD; Ashley E. Ross, MD, PhD; Alicia K. Morgans, MD, MPH; and Jorge A. Garcia, MD, outline the abscopal effect in treating patients with metastatic prostate cancer.
Views: 904 OncLiveTV
What Are The Treatment Options For Castration-resistant Prostate Cancer?
 
01:01
http://www.balancedhealthtoday.com http://www.balancedhealthtoday.com/endosterol.html Treatments for castration-resistant prostate cancer include: Antiandrogens, such as flutamide, bicalutamide, nilutamide, and enzalutamide. Androgen synthesis inhibitors, such as ketoconazole, aminoglutethamide, and abiraterone acetate. Immunotherapy using a cell-based vaccine called sipuleucel-T. This vaccine uses a man’s own immune cells to fight metastatic prostate cancer that has become resistant to hormone therapy. Chemotherapy, most commonly with the drug docetaxel. Another drug, cabazitaxel, is approved for the treatment of metastatic castration-resistant prostate cancer that was previously treated with docetaxel. Radium 223 dichloride, a radiopharmaceutical approved to treat men with castration-resistant prostate cancer that has metastasized (spread) to the bones and is causing symptoms but has not spread to other organs. This drug collects in certain areas of bone, such as bone metastases, and gives off radiation that kills cancer cells. Men with castration-resistant prostate cancer who receive these treatments will continue to take first-line hormone therapy (e.g., an LHRH agonist) to avoid an increase in testosterone level, which may lead to tumor progression in some men. Randomized clinical trials have demonstrated that treatment with abiraterone acetate or enzalutamide prolongs survival among men with metastatic castration-resistant prostate cancer, whether or not they have previously received chemotherapy. http://www.balancedhealthtoday.com/store http://www.balancedhealthtoday.com/store/endosterol.html
Views: 2096 Martina Santiago
New prostate cancer treatment 3D Prostate Targeted Treatment  Natural  Effective no side effect
 
00:27
For prostate cancer, our treatment consists of several steps. First, we determine the location and size of the prostate cancer lesions by Digital Rectal Examination (DRE), Trans Rectal UltraSound (TRUS), and pelvic Nuclear Magnetic Resonance Imaging (MRI) examination. And then we targeted inject a set of anti-cancer herbal extracts without any side effects into the prostate cancer lesion area in high concentrations by using 3D targeted injection technology, thus directly inhibiting and killing cancer cells, making the prostate cancerous tissue atrophy and necrotize. At the same time, we targeted inject unblocking herbal extracts without any side effects to resolve the pathogenic tissue and prostatic endotoxin, and discharge toxic substances. In addition, we use some other herbal extracts without any side effects to improve and restore prostate immunity and the blood circulation to prevent the recurrence of prostate cancer. Through 3D Prostate Targeted Treatment, the volume of the prostate cancer lesions will shrink or disappear, and the patient’s symptoms should be improved or disappear. At the first and second clinical stages (I-II stages), prostate cancer lesion is only confined to the prostate capsule. At this time, we inject a set of anti-cancer herbal extracts and unblocking herbal extracts within the prostate cancer lesion for treatment. At the third clinical stage (III stage), prostate cancer lesion goes beyond the prostate capsule and invades neighboring tissues and organs like seminal vesicle, bladder neck etc. We targeted inject treatment medicines within the prostate capsule to treat the primary lesion, and we also apply 3D targeted injection technology to put a set of anti-cancer treatment medications into adjacent seminal vesicle, the bladder neck and other neighboring tissues and organs for treatment. At the fourth clinical stage (IV stage), prostate cancer lesion spreads beyond the prostate by transferring lesions to distant bones, or even lungs, liver and adrenal gland. We targeted inject treatment medicines within the prostate capsule to treat the primary lesion; at the same time, we couple with systemic treatment and local targeted injection treatment of distant metastasis lesions. The treatment medications include anti-cancer herbal extracts, unblocking herbal extracts, and improving immunity herbal extracts. Our clinical use of medicines have no side effects. Because prostate cancer normally happens in older people, the cancer nodules will press on the prostate tubes, ejaculatory ducts and posterior urethra, prostate cancer patients usually may also have prostatitis and genitourinary tract infection, 3D Prostate Targeted Treatment can treat these diseases at the same time. 3D Prostate Targeted Treatment is very suitable for prostate cancer patients who also have prostatitis and benign prostatic hyperplasia. 3D Prostate Targeted Treatment is an non-surgical method that causes no harm, no side-effects with no ongoing consequences of the original disease, to completely treat prostate cancer. 3D Prostate Targeted Treatment is not a long-term medicinal treatment and so it is the best treatment for prostate cancer as it causes no side-effects. At present, 3D Prostate Targeted Treatment is not suitable for distant metastases of prostate cancer, including bone metastases, lung metastases, liver metastases and adrenal glands metastases. 3D prostatitis and Prostate Clinic Miss Alisa Wang English Assistant to Dr. Song Tel:86-186-7321-6429 WhatsApp:+ 86 -186-73216429 Email: prostatecure3d@gmail.com Website: https://www.prostatecancer.vip/cancer.html The Xiangtan 3D Urology and Prostate Clinics Address - Jin Xiangtan Square Office Building, Suite 801, Shao Shan Middle Rd., Xiangtan, Hunan, China.
Views: 11079 Alisa Wang
Prostate Cancer Survival Rates- Stage 4 Prostate Cancer Survival Rates
 
00:37
18 dec 2017 the relative 5 year survival rate for regional stage prostate cancer is nearly 100. The study included 790 men with hormone sensitive metastatic prostate cancer. See data for age, trends over time, uk region and more 27 sep 2016 survival rates. It includes seer summary stagescancer histologic typesage at initial diagnosisrace2010 aug;184(2) 512 8. Author information (1)department of urology, emory university school 22 nov 2017 this is known as stage iv prostate cancer and said to be metastatic. Prostate cancer t1 t2 t3 t4 learn about stage progression. Researchers hailed the results as good news, saying they had been expecting a survival rate of 90. 50 deaths per 100 person years a 28. Almost all men with early prostate cancer survive 10 years. 010stage iv prostate cancer survival differences in clinical t4, nodal and metastatic disease. The results are below 7 mar 2016 for metastatic prostate cancer, patients whose cancer spreads to the lymph survive longest overall, men fare worst when liver is involved survival rate exceptionally high. Googleusercontent search. Men treated with adt docetaxel had a median overall survival rate of 57. According to the american cancer society's relative survival rates, which account for patients with all stages of prostate 8 dec 2017 treatment options under clinical evaluation stage iv cancer; Current trials as a result, gleason score standardized mortality rates these men were artifactually improved from 2. As with all cancers, doctors use the term stage to describe how far prostate cancer has spreadthe staging system for most including cancer, uses three different aspects of tumour growth and spread. High grade prostate cancer, particularly the percentage presence of gleason grades 4 and 5, is associated with adverse pathologic findings disease chart below reflects ctca seer survival rates for cancer patients distant (metastatic) who were diagnosed between 2000 2013. Survival rates for prostate cancer american society. For these cancers, the 5 year survival rate is 29. 23 jul 2016 on various websites it states that the 5 year after diagnosis survival rate for those with prostate cancer with bone metastases is 3 percent. It's also important to 12 oct 2017 continuous advances have provided a new understanding of the diagnosis, staging, and treatment metastatic advanced prostate cancer. Prostate cancer t1 t2 t3 t4 learn about stage progression survival rates for prostate american society. How is survival affected? A study by researchers in denmark investigated the effect that bone metastasis had on rates for men with prostate cancer. Newly diagnosed with prostate cancer bootswebmd. Months compared to only 44 for those treated with adt unknown reasons, the risk of prostate cancer is 74. Prostate cancer treatment (pdq) health professional version survival rates for prostate with bone metastases advanced early stage treat or wait? Harvard metastatic and overview, epidemiology statistics & results iv di
Views: 209 health tips